CS logo
small CS logo
GW Research Inc

Chula Vista, California, United States
Research institute in Chula Vista, California
353 Church Ave, Chula Vista, CA 91910

About GW Research Inc


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Allergan
5
Phathom Pharmaceuticals, Inc.
4
Exact Sciences Corporation
3
Ironwood Pharmaceuticals, Inc.
3
Shire
3
Bausch Health Americas, Inc.
2
Ferring Pharmaceuticals
2
Arena Pharmaceuticals
1
Genfit
1
Intercept Pharmaceuticals
1
Inventiva Pharma
1
Total Rows: 19

Clinical Trials at GW Research Inc


During the past decade, GW Research Inc conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 24 clinical trials were completed, i.e. on average, 82.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 18 clinical trials were completed. i.e. 360% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33332288881133111100112222228877Started TrialsCompleted Trails201520162017201820192020202120220246810
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prevention of Recurrence of Diverticulitis
2007-11-28
2012-03-05
Completed
590
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
2010-05-01
2013-06-01
Completed
611
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
2011-10-01
2012-12-01
Completed
951
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
2012-11-01
2014-10-01
Completed
428
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
2013-04-01
2014-05-01
Terminated
376
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
2015-02-01
2016-12-01
Terminated
71
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
2015-09-22
2025-09-01
Active, not recruiting
2,480
A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved
2015-12-07
2019-02-15
Completed
318

Rows per page:

1–34 of 34

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "GW Research Inc" #1 sponsor was "Allergan" with 5 trials, followed by "Phathom Pharmaceuticals, Inc." with 4 trials sponsored, "Exact Sciences Corporation" with 3 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 3 trials sponsored and "Shire" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "GW Research Inc" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Parexel" with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator, "Sucampo AG" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAllergan: 5Allergan: 5PhathomPharmaceuticals, Inc.: 4PhathomPharmaceuticals, Inc.: 4Exact Sciences Corporation: 3Exact Sciences Corporation: 3IronwoodPharmaceuticals, Inc.: 3IronwoodPharmaceuticals, Inc.: 3Shire: 3Shire: 3Bausch Health Americas, Inc.: 2Bausch Health Americas, Inc.: 2Ferring Pharmaceuticals: 2Ferring Pharmaceuticals: 2Arena Pharmaceuticals: 1Arena Pharmaceuticals: 1Genfit: 1Genfit: 1Intercept Pharmaceuticals: 1Intercept Pharmaceuticals: 1

Created with Highcharts 11.1.0Top CollaboratorsAllergan Sales, LLC: 2Allergan Sales, LLC: 2Parexel: 1Parexel: 1RTI Health Solutions: 1RTI Health Solutions: 1Sucampo AG: 1Sucampo AG: 1Takeda: 1Takeda: 1

Clinical Trials Conditions at GW Research Inc


According to Clinical.Site data, the most researched conditions in "GW Research Inc" are "Gastroparesis" (5 trials), "Colorectal Cancer" (3 trials), "Diabetes Mellitus" (3 trials), "Irritable Bowel Syndrome" (3 trials) and "Chronic Idiopathic Constipation" (2 trials). Many other conditions were trialed in "GW Research Inc" in a lesser frequency.

Clinical Trials Intervention Types at GW Research Inc


Most popular intervention types in "GW Research Inc" are "Drug" (31 trials), "Other" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (26 trials), "Vonoprazan" (4 trials), "Relamorelin" (3 trials), "Lansoprazole" (2 trials) and "Oral Budesonide Suspension (OBS)" (2 trials). Other intervention names were less common.

Clinical Trials Genders at GW Research Inc


The vast majority of trials in "GW Research Inc" are 32 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at GW Research Inc


Currently, there are NaN active trials in "GW Research Inc". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in GW Research Inc, undefined suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in GW Research Inc, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 20Phase 3: 20Phase 2: 11Phase 2: 11Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 18Completed: 18Terminated: 10Terminated: 10Active, not recruiting: 5Active, not recruiting: 5Recruiting: 1Recruiting: 1